Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Sumitomo Dainippon

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Sumitomo Dainippon 's Japan sales performance.

ds-pharma

Myovant preps US filing for relugolix in prostate cancer

Myovant preps US filing for relugolix in prostate cancer

The positive trial result is also good news for Japanese drugmaker  Sumitomo Dainippon, which agreed a $3bn upfront deal to acquire a 45% stake in Myovant – and control of four other

Sumitomo Dainippon goes big on biotech with $3bn Roivant deal

Sumitomo Dainippon goes big on biotech with $3bn Roivant deal Could acquire up to 11 Roivant spinouts. Japanese pharma company Sumitomo Dainippon has announced a strategic deal with Roivant Sciences, a biotech holding company headed by entrepreneur Vivek Ramaswamy, for a ... Sumitomo Dainippon's expertise in

Metavant/Poxel prep phase 3 for imeglimin in diabetic kidney disease

Metavant/Poxel prep phase 3 for imeglimin in diabetic kidney disease drug. The French company signed an agreement with Sumitomo Dainippon Pharma in 2017 for development rights to the drug in Asian markets including Japan, which has a slightly lower bar for

After Axovant shock, Roivant pens diabetes deal with Poxel

After Axovant shock, Roivant pens diabetes deal with Poxel The drug is already in phase III testing in Japan via a partnership with Sumitomo Dainippon Pharma, and Roivant will now take the lead on phase III trials in the US, ... Europe and other territories not covered by the Sumitomo alliance.

The good, the bad and the ugly

The good, the bad and the ugly 2020.”. Central Nervous System. 2017 was a quiet year in CNS. The most prominent growing companies were Merck &Co (49.8%), Takeda (39.1%) and Sumitomo Dainippon Pharma (25%), with growth ... However, the imminent US patent expiry of Sumitomo

1 2 3 4 5 6 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
90TEN

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...
Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...

Infographics